The association between asthma control, health care costs, and quality of life in France and Spain

Author:

Doz Marianne,Chouaid Christos,Com-Ruelle Laure,Calvo Eduardo,Brosa Max,Robert Julien,Decuypère Laurent,Pribil Celine,Huerta Alicia,Detournay Bruno

Abstract

Abstract Background Current asthma management guidelines are based on the level of asthma control. The impact of asthma control on health care resources and quality of life (QoL) is insufficiently studied. EUCOAST study was designed to describe costs and QoL in adult patients according to level of asthma control in France and Spain. Methods An observational cost of illness study was conducted simultaneously in both countries among patients age greater or equal to 18 with a diagnosis of asthma for at least 12 months. Patients were recruited prospectively by GPs in 2010 in four waves to avoid a seasonal bias. Health care resources utilization of the three months before the inclusion was collected through physician questionnaires. Asthma control was evaluated using 2009 GINA criteria over a 3-month period. QoL was assessed using EQ-5D-3L®. Results 2,671 patients (France: 1,154; Spain: 1,517) were enrolled. Asthma was controlled in 40.6% [95% CI: 37.7% - 43.4%] and 29.9% [95% CI: 27.6% - 32.3%] of French and Spanish patients respectively. For all types of costs, the percentage of patients using health care resources varied significantly according to the level of asthma control. The average cost (euros/3-months/patient) of controlled asthma was €85.4 (SD: 153.5) in France compared with €314.0 (SD: 2,160.4) for partially controlled asthma and €537.9 (SD: 2,355.7) for uncontrolled asthma (p<0.0001). In Spain, the corresponding figures were €152.6 (SD: 162.1), €241.2 (SD: 266.8), and €556.8 (SD: 762.4). EQ-5D-3L® score was higher (p<0.0001) in patients with controlled asthma compared to partially controlled and uncontrolled asthma in both countries (respectively 0.88; 0.78; 0.63 in France and 0.89; 0.82; 0.69 in Spain). Conclusions In both countries, patients presenting with uncontrolled asthma had a significantly higher asthma costs and lower scores of Qol compared to the others.

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine

Reference30 articles.

1. Global Strategy for Asthma Management and Prevention. 2009, Global Initiative for Asthma (GINA), [Report accessed on www.ginasthma.org, in September 2011]

2. Masoli M, Fabian D, Holt S, Beasley R, Medical Research Institute of New Zealand, Wellington, New Zealand University of Southampton Southampton, United Kingdom: The Global Burden of Asthma Report, Global Initiative for Asthma (GINA). http://www.ginasthma.org/local/uploads/files/GINABurdenReport_1.pdf,

3. Afrite A, Allonier C, Com-Ruelle L, Le Guen N: L’asthme en France en 2006: prévalence et contrôle des symptômes. Issues Health Econ (Questions d'économie de la santé). 2008, 138: 1-8.

4. Urrutia I, Aguirre U, Sunyer J, Plana E, Muniozguren N, Martinez-Moratalla J, Payo F, Maldonado JA, Anto JM, Estudio de Salud Respiratoria de la Comunidad Europea: Changes in the prevalence of asthma in the Spanish cohort of the European Community Respiratory Health Survey (ECRHS-II). Arch Bronconeumol. 2007, 43 (8): 425-430.

5. Kroegel C, Wirtz H: History of guidelines for the diagnosis and management of asthma: from opinion to control. Drugs. 2009, 69 (9): 1189-1204. 10.2165/00003495-200969090-00004.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3